Document Detail


Review of current therapies for secondary hypertrophic pulmonary osteoarthropathy.
MedLine Citation:
PMID:  20936419     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hypertrophic osteoarthropathy (HOA) is a disabling condition that may occur secondarily to primary lung cancer. It is characterized by digital clubbing, arthralgia/arthritis, and periostosis of the tubular bones. The pain associated with HOA can be disabling and often refractory to conventional analgesics. We performed a comprehensive review of the literature using the PubMed database on treatment modalities available for HOA. We found 52 relevant articles-40 case reports, six case series, two review papers, and four combined case series and review papers. There were no randomized controlled trials reported. We then classified treatments used for HOA into two categories: (1) treatment of primary cause (i.e., resection of tumor, chemotherapy, radiotherapy, treatment of infection, etc.) and (2) symptomatic treatments (i.e., bisphosphonates, octreotide, NSAIDs, vagotomy, etc.). Subsequently, we summarized the main findings for each treatment. Although the clinical diagnosis of HOA has existed for over 100 years, the pathogenesis mechanism has not yet been elucidated, and treatment options for this condition remain experimental. Primary treatment is the most widely reported modality to be efficacious. In cases which primary therapy is not possible, several symptomatic treatment modalities are suggested, with various degree of success. Further research is needed to clarify the pathophysiological mechanism of HOA as to appropriately direct therapy.
Authors:
Sheila Nguyen; Mehrnaz Hojjati
Related Documents :
23466309 - Intraosseous lipoma of the calcaneus: report of a case and review of the literature.
10986679 - Self-administered topical imiquimod treatment of vulvar intraepithelial neoplasia. a re...
18203669 - Atrophy of the intrinsic musculature of the hands associated with the use of botulinum ...
20377539 - Therapeutic management of neonatal chylous ascites: report of a case and review of the ...
20493999 - Diaphragm plication for eventration or paralysis: a review of the literature.
24529569 - Treatment of a rare ganglioneuroma with resection and reconstruction of the mandible: a...
21843709 - Perineal mass protrusion with rectal mucosa: a rectal duplication that underwent exstro...
11217819 - Severe symptomatic hyponatremia during citalopram therapy.
20122539 - Refeeding syndrome: treatment considerations based on collective analysis of literature...
Publication Detail:
Type:  Journal Article; Review     Date:  2010-10-09
Journal Detail:
Title:  Clinical rheumatology     Volume:  30     ISSN:  1434-9949     ISO Abbreviation:  Clin. Rheumatol.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-01-03     Completed Date:  2011-04-06     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  8211469     Medline TA:  Clin Rheumatol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  7-13     Citation Subset:  IM    
Affiliation:
University of Minnesota Medical School, Minneapolis, MN, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Antineoplastic Agents / pharmacology
Diphosphonates / chemistry
Female
Humans
Lung Neoplasms / complications*
Male
Middle Aged
Octreotide / pharmacology
Osteoarthropathy, Secondary Hypertrophic / complications,  therapy*
Pain
Quinazolines / pharmacology
Rheumatology / methods*
Treatment Outcome
Vagotomy / methods
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Diphosphonates; 0/Quinazolines; 83150-76-9/Octreotide; S65743JHBS/gefitinib

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The pedunculopontine tegmental nucleus: from basic neuroscience to neurosurgical applications: arous...
Next Document:  Linear accelerator-based stereotactic radiosurgery of intracranial meningiomas: results of the first...